gnipt by tmps or mpss Search Results


93
TargetMol bfgf
Bfgf, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/FGF-2+Protein%2C+Salmon%2C+Recombinant/pm39613390-35-73-74
Average 93 stars, based on 1 article reviews
bfgf - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

88
TargetMol tofacitinib
Fig. 1. Differential expression and phosphoryla tion of STAT1 in eosinophils from allergic and healthy non-allergic donors. (A) Purified eosino phils from allergic (n = 10) and healthy donors (n = 12) were fixed and permeabilized, stained with the respective isotype control or specific antibodies against total-STAT1 and phospho-STAT1 and measured by flow cytometry. Data were analyzed as fold increase in fluorescence intensity with respect to the isotype control and reported as phospho-STAT1/ total-STAT1 (mean ± SEM). ** P < 0.01; Student’s t-test. (B-D) Purified eosinophils from healthy donors were pretreated with (B) vehicle (n = 7), (C) bar icitinib (BARI, 200 nM, n = 6) or (D) <t>tofacitinib</t> (TOFA, 200 nM, n = 6) for 30 min at 37 ◦C, stimu lated with vehicle or IL-5 (300 pM) for 10 min at 37 ◦C, fixed and permeabilized, stained with isotype control or a phospho-STAT1 antibody and analyzed by flow cytometry. Data are expressed as fold in crease in fluorescence intensity with respect to the isotype control (mean ± SEM). * P < 0.05; Student’s t-test.
Tofacitinib, supplied by TargetMol, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/IL-5+Protein%2C+Human%2C+Recombinant/pm34274356-88-16-19
Average 88 stars, based on 1 article reviews
tofacitinib - by Bioz Stars, 2026-10
88/100 stars
  Buy from Supplier

90
Verlag GmbH tmps
Fig. 1. Differential expression and phosphoryla tion of STAT1 in eosinophils from allergic and healthy non-allergic donors. (A) Purified eosino phils from allergic (n = 10) and healthy donors (n = 12) were fixed and permeabilized, stained with the respective isotype control or specific antibodies against total-STAT1 and phospho-STAT1 and measured by flow cytometry. Data were analyzed as fold increase in fluorescence intensity with respect to the isotype control and reported as phospho-STAT1/ total-STAT1 (mean ± SEM). ** P < 0.01; Student’s t-test. (B-D) Purified eosinophils from healthy donors were pretreated with (B) vehicle (n = 7), (C) bar icitinib (BARI, 200 nM, n = 6) or (D) <t>tofacitinib</t> (TOFA, 200 nM, n = 6) for 30 min at 37 ◦C, stimu lated with vehicle or IL-5 (300 pM) for 10 min at 37 ◦C, fixed and permeabilized, stained with isotype control or a phospho-STAT1 antibody and analyzed by flow cytometry. Data are expressed as fold in crease in fluorescence intensity with respect to the isotype control (mean ± SEM). * P < 0.05; Student’s t-test.
Tmps, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/tmps/pm29740924-813-1-14
Average 90 stars, based on 1 article reviews
tmps - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Taiyo Kagaku Co mesoporous silica tmps-1.5
Fig. 1. Differential expression and phosphoryla tion of STAT1 in eosinophils from allergic and healthy non-allergic donors. (A) Purified eosino phils from allergic (n = 10) and healthy donors (n = 12) were fixed and permeabilized, stained with the respective isotype control or specific antibodies against total-STAT1 and phospho-STAT1 and measured by flow cytometry. Data were analyzed as fold increase in fluorescence intensity with respect to the isotype control and reported as phospho-STAT1/ total-STAT1 (mean ± SEM). ** P < 0.01; Student’s t-test. (B-D) Purified eosinophils from healthy donors were pretreated with (B) vehicle (n = 7), (C) bar icitinib (BARI, 200 nM, n = 6) or (D) <t>tofacitinib</t> (TOFA, 200 nM, n = 6) for 30 min at 37 ◦C, stimu lated with vehicle or IL-5 (300 pM) for 10 min at 37 ◦C, fixed and permeabilized, stained with isotype control or a phospho-STAT1 antibody and analyzed by flow cytometry. Data are expressed as fold in crease in fluorescence intensity with respect to the isotype control (mean ± SEM). * P < 0.05; Student’s t-test.
Mesoporous Silica Tmps 1.5, supplied by Taiyo Kagaku Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/mesoporous+silica+tmps+4/10__1016_slash_j__micromeso__2020__110743-46-0-3
Average 90 stars, based on 1 article reviews
mesoporous silica tmps-1.5 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Premaitha Health PLC gnipt by tmps
Difference between massively parallel shotgun sequencing (MPSS) and targeted massively parallel sequencing <t>(TMPS).</t> Genomics‐based non‐invasive prenatal testing <t>(gNIPT)</t> aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.
Gnipt By Tmps, supplied by Premaitha Health PLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/gnipt+by+tmps++selective+amplification+of+fetal+dna+/pmc06486016-3100-5-14
Average 90 stars, based on 1 article reviews
gnipt by tmps - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Cosmocyte Inc tmps carrying sonic hedgehog
Difference between massively parallel shotgun sequencing (MPSS) and targeted massively parallel sequencing <t>(TMPS).</t> Genomics‐based non‐invasive prenatal testing <t>(gNIPT)</t> aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.
Tmps Carrying Sonic Hedgehog, supplied by Cosmocyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/tmps+carrying+sonic+hedgehog/10__1161_slash_circresaha__110__233403-81-0-15
Average 90 stars, based on 1 article reviews
tmps carrying sonic hedgehog - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BGI Shenzhen gnipt by tmps or mpss
Difference between massively parallel shotgun sequencing <t>(MPSS)</t> and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal <t>testing</t> <t>(gNIPT)</t> aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.
Gnipt By Tmps Or Mpss, supplied by BGI Shenzhen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/gnipt+by+tmps+or+mpss/pmc06486016-3028-9-20
Average 90 stars, based on 1 article reviews
gnipt by tmps or mpss - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Taiyo Kagaku Co tmps
Difference between massively parallel shotgun sequencing <t>(MPSS)</t> and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal <t>testing</t> <t>(gNIPT)</t> aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.
Tmps, supplied by Taiyo Kagaku Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/tmps/us08475964-102-2-7
Average 90 stars, based on 1 article reviews
tmps - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Monsanto Technology LLC 5,10,15,20- tetrakis-(2-fluorophenyl)porphyrin
Difference between massively parallel shotgun sequencing <t>(MPSS)</t> and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal <t>testing</t> <t>(gNIPT)</t> aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.
5,10,15,20 Tetrakis (2 Fluorophenyl)porphyrin, supplied by Monsanto Technology LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/5+10+15+20+tetrakis+2++4++6++trimethyl+3+5+disulfonatophenyl+porphyrinatoferrate+7++++fe+tmps+/pm22835771-298-10-4
Average 90 stars, based on 1 article reviews
5,10,15,20- tetrakis-(2-fluorophenyl)porphyrin - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Ruihua Certified Public Accountants LLP tmps
Difference between massively parallel shotgun sequencing <t>(MPSS)</t> and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal <t>testing</t> <t>(gNIPT)</t> aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.
Tmps, supplied by Ruihua Certified Public Accountants LLP, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/tmps/10__1186_slash_s12645___022___00125___y-109-16-11
Average 90 stars, based on 1 article reviews
tmps - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

92
TargetMol trail
Difference between massively parallel shotgun sequencing <t>(MPSS)</t> and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal <t>testing</t> <t>(gNIPT)</t> aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.
Trail, supplied by TargetMol, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/TRAIL-TNFSF10+Protein%2C+Mouse%2C+Recombinant/10__1096_slash_fj__202301755r-38-29-32
Average 92 stars, based on 1 article reviews
trail - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

94
TargetMol recombinant human vascular endothelial growth factor 165
Difference between massively parallel shotgun sequencing <t>(MPSS)</t> and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal <t>testing</t> <t>(gNIPT)</t> aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.
Recombinant Human Vascular Endothelial Growth Factor 165, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gnipt+by+tmps+or+mpss/VEGF165+Protein%2C+Human%2C+Recombinant/pm42176839-49-24-32
Average 94 stars, based on 1 article reviews
recombinant human vascular endothelial growth factor 165 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. Differential expression and phosphoryla tion of STAT1 in eosinophils from allergic and healthy non-allergic donors. (A) Purified eosino phils from allergic (n = 10) and healthy donors (n = 12) were fixed and permeabilized, stained with the respective isotype control or specific antibodies against total-STAT1 and phospho-STAT1 and measured by flow cytometry. Data were analyzed as fold increase in fluorescence intensity with respect to the isotype control and reported as phospho-STAT1/ total-STAT1 (mean ± SEM). ** P < 0.01; Student’s t-test. (B-D) Purified eosinophils from healthy donors were pretreated with (B) vehicle (n = 7), (C) bar icitinib (BARI, 200 nM, n = 6) or (D) tofacitinib (TOFA, 200 nM, n = 6) for 30 min at 37 ◦C, stimu lated with vehicle or IL-5 (300 pM) for 10 min at 37 ◦C, fixed and permeabilized, stained with isotype control or a phospho-STAT1 antibody and analyzed by flow cytometry. Data are expressed as fold in crease in fluorescence intensity with respect to the isotype control (mean ± SEM). * P < 0.05; Student’s t-test.

Journal: Biochemical pharmacology

Article Title: The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

doi: 10.1016/j.bcp.2021.114690

Figure Lengend Snippet: Fig. 1. Differential expression and phosphoryla tion of STAT1 in eosinophils from allergic and healthy non-allergic donors. (A) Purified eosino phils from allergic (n = 10) and healthy donors (n = 12) were fixed and permeabilized, stained with the respective isotype control or specific antibodies against total-STAT1 and phospho-STAT1 and measured by flow cytometry. Data were analyzed as fold increase in fluorescence intensity with respect to the isotype control and reported as phospho-STAT1/ total-STAT1 (mean ± SEM). ** P < 0.01; Student’s t-test. (B-D) Purified eosinophils from healthy donors were pretreated with (B) vehicle (n = 7), (C) bar icitinib (BARI, 200 nM, n = 6) or (D) tofacitinib (TOFA, 200 nM, n = 6) for 30 min at 37 ◦C, stimu lated with vehicle or IL-5 (300 pM) for 10 min at 37 ◦C, fixed and permeabilized, stained with isotype control or a phospho-STAT1 antibody and analyzed by flow cytometry. Data are expressed as fold in crease in fluorescence intensity with respect to the isotype control (mean ± SEM). * P < 0.05; Student’s t-test.

Article Snippet: In some experiments eosinophils from healthy donors were pretreated with vehicle, baricitinib (200 nM; TargetMol) or tofacitinib (200 nM; TargetMol) for 30 min at 37 ◦C and stimulated with vehicle or IL-5 (100 pM) for 10 min at 37 ◦C prior to the staining.

Techniques: Quantitative Proteomics, Purification, Staining, Control, Flow Cytometry, Fluorescence

Fig. 2. Baricitinib and tofacitinib similarly inhibit eosinophil differentiation and JAK1/2 activation. Bone marrow cells were collected from the femurs and tibiae of three female BALB/c mice and cultured at 106/mL in media supplemented with 100 ng/mL SCF and 100 ng/mL FLT3L from day 0 to day 4. On day 4, media were replaced with media containing 10 ng/mL IL-5 supplemented with or without baricitinib (BARI, 200 nM) or tofacitinib (TOFA, 200 nM). (A) Total cells, (B) Siglec F positive cells and (C) CCR3 positive cells were enumerated by flow cytometry on the indicated days. On day 12 (D) JAK1 and (E) JAK2 phosphorylation was measured by flow cytometric intracellular staining. Data are shown as mean ± SEM from 3 independent experiments, ** P < 0.01, *** P < 0.005; (A-C) two-way ANOVA and (D and E) one- way ANOVA.

Journal: Biochemical pharmacology

Article Title: The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

doi: 10.1016/j.bcp.2021.114690

Figure Lengend Snippet: Fig. 2. Baricitinib and tofacitinib similarly inhibit eosinophil differentiation and JAK1/2 activation. Bone marrow cells were collected from the femurs and tibiae of three female BALB/c mice and cultured at 106/mL in media supplemented with 100 ng/mL SCF and 100 ng/mL FLT3L from day 0 to day 4. On day 4, media were replaced with media containing 10 ng/mL IL-5 supplemented with or without baricitinib (BARI, 200 nM) or tofacitinib (TOFA, 200 nM). (A) Total cells, (B) Siglec F positive cells and (C) CCR3 positive cells were enumerated by flow cytometry on the indicated days. On day 12 (D) JAK1 and (E) JAK2 phosphorylation was measured by flow cytometric intracellular staining. Data are shown as mean ± SEM from 3 independent experiments, ** P < 0.01, *** P < 0.005; (A-C) two-way ANOVA and (D and E) one- way ANOVA.

Article Snippet: In some experiments eosinophils from healthy donors were pretreated with vehicle, baricitinib (200 nM; TargetMol) or tofacitinib (200 nM; TargetMol) for 30 min at 37 ◦C and stimulated with vehicle or IL-5 (100 pM) for 10 min at 37 ◦C prior to the staining.

Techniques: Activation Assay, Cell Culture, Flow Cytometry, Phospho-proteomics, Staining

Fig. 3. Effects of baricitinib and tofacitinib on eosinophil migratory responsiveness. (A) Purified eosinophils were seeded on L-lysine coated chamber slides and pretreated with baricitinib (200 nM), tofacitinib (200 nM) or vehicle for 30 min at room temperature. F-actin polymerization was induced by stimulation with IL- 5 (1 nM) at 37 ◦C for 15 min. Adherent cells were fixed, permeabilized and blocked prior to F-actin staining with Phalloidin-Texas Red. Slides were mounted with mounting media with DAPI and fluorescence images were taken by an Olympus IX70 microscope connected with a Hamamatsu ORCA-ER digital camera. Olympus xcellence® imaging analysis software 1.1 was used for acquiring images. Representative pictures of 4 independent experiments are shown. (B-E) Purified eosinophils (n = 4–16) were pretreated with vehicle, baricitinib (BARI, 200 nM or 500 nM) (B and D) or tofacitinib (TOFA, 200 nM or 500 nM) (C and E) for 30 min at 37 ◦C and were allowed to migrate towards eosinophil chemoattractants: IL-5 300 pM, complement 5a 10 nM, CCL11 10 nM and PGD2 30 nM for 60 min in a 48-well micro- Boyden chamber. Migrated cells were enumerated by flow cytometry (BD FACSCanto II, high flow-rate for 30 s). Data are shown as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.005; Student’s t-test.

Journal: Biochemical pharmacology

Article Title: The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

doi: 10.1016/j.bcp.2021.114690

Figure Lengend Snippet: Fig. 3. Effects of baricitinib and tofacitinib on eosinophil migratory responsiveness. (A) Purified eosinophils were seeded on L-lysine coated chamber slides and pretreated with baricitinib (200 nM), tofacitinib (200 nM) or vehicle for 30 min at room temperature. F-actin polymerization was induced by stimulation with IL- 5 (1 nM) at 37 ◦C for 15 min. Adherent cells were fixed, permeabilized and blocked prior to F-actin staining with Phalloidin-Texas Red. Slides were mounted with mounting media with DAPI and fluorescence images were taken by an Olympus IX70 microscope connected with a Hamamatsu ORCA-ER digital camera. Olympus xcellence® imaging analysis software 1.1 was used for acquiring images. Representative pictures of 4 independent experiments are shown. (B-E) Purified eosinophils (n = 4–16) were pretreated with vehicle, baricitinib (BARI, 200 nM or 500 nM) (B and D) or tofacitinib (TOFA, 200 nM or 500 nM) (C and E) for 30 min at 37 ◦C and were allowed to migrate towards eosinophil chemoattractants: IL-5 300 pM, complement 5a 10 nM, CCL11 10 nM and PGD2 30 nM for 60 min in a 48-well micro- Boyden chamber. Migrated cells were enumerated by flow cytometry (BD FACSCanto II, high flow-rate for 30 s). Data are shown as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.005; Student’s t-test.

Article Snippet: In some experiments eosinophils from healthy donors were pretreated with vehicle, baricitinib (200 nM; TargetMol) or tofacitinib (200 nM; TargetMol) for 30 min at 37 ◦C and stimulated with vehicle or IL-5 (100 pM) for 10 min at 37 ◦C prior to the staining.

Techniques: Purification, Staining, Fluorescence, Microscopy, Imaging, Software, Flow Cytometry

Fig. 4. Effects of baricitinib and tofacitinib on neutrophil chemotaxis. PMNL (n = 14) were pre treated with vehicle, baricitinib (BARI, 500 nM) or tofacitinib (TOFA, 500 nM) for 30 min at 37 ◦C and were allowed to migrate towards neutrophil chemo attractants: IL-8 (10 nM) and complement 5a (10 nM) for 60 min in a 48-well micro-Boyden chamber. Migrated cells were enumerated by flow cytometry (BD FACSCanto II, high flow-rate for 30 min). Data are shown as mean ± SEM. * P < 0.05; Student’s t- test.

Journal: Biochemical pharmacology

Article Title: The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

doi: 10.1016/j.bcp.2021.114690

Figure Lengend Snippet: Fig. 4. Effects of baricitinib and tofacitinib on neutrophil chemotaxis. PMNL (n = 14) were pre treated with vehicle, baricitinib (BARI, 500 nM) or tofacitinib (TOFA, 500 nM) for 30 min at 37 ◦C and were allowed to migrate towards neutrophil chemo attractants: IL-8 (10 nM) and complement 5a (10 nM) for 60 min in a 48-well micro-Boyden chamber. Migrated cells were enumerated by flow cytometry (BD FACSCanto II, high flow-rate for 30 min). Data are shown as mean ± SEM. * P < 0.05; Student’s t- test.

Article Snippet: In some experiments eosinophils from healthy donors were pretreated with vehicle, baricitinib (200 nM; TargetMol) or tofacitinib (200 nM; TargetMol) for 30 min at 37 ◦C and stimulated with vehicle or IL-5 (100 pM) for 10 min at 37 ◦C prior to the staining.

Techniques: Chemotaxis Assay, Flow Cytometry

Fig. 5. Effects of baricitinib and tofacitinib on eosinophil ROS production. Purified eosinophils were pretreated with vehicle, baricitinib (BARI, 500 nM) or tofacitinib (TOFA, 500 nM) for 30 min at 37 ◦C and ROS production was induced by IL-5 (A, n = 4–8), complement 5a (B, n = 6), CCL11 (C, n = 5–8) and PGD2 (D, n = 7–9). ROS production was detected by flow cytometry using a dihydrorhodamin-123 based assay. Data are expressed as geometric mean fluorescence intensity (MFI) and shown as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.005; two-way ANOVA.

Journal: Biochemical pharmacology

Article Title: The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

doi: 10.1016/j.bcp.2021.114690

Figure Lengend Snippet: Fig. 5. Effects of baricitinib and tofacitinib on eosinophil ROS production. Purified eosinophils were pretreated with vehicle, baricitinib (BARI, 500 nM) or tofacitinib (TOFA, 500 nM) for 30 min at 37 ◦C and ROS production was induced by IL-5 (A, n = 4–8), complement 5a (B, n = 6), CCL11 (C, n = 5–8) and PGD2 (D, n = 7–9). ROS production was detected by flow cytometry using a dihydrorhodamin-123 based assay. Data are expressed as geometric mean fluorescence intensity (MFI) and shown as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.005; two-way ANOVA.

Article Snippet: In some experiments eosinophils from healthy donors were pretreated with vehicle, baricitinib (200 nM; TargetMol) or tofacitinib (200 nM; TargetMol) for 30 min at 37 ◦C and stimulated with vehicle or IL-5 (100 pM) for 10 min at 37 ◦C prior to the staining.

Techniques: Purification, Flow Cytometry, Fluorescence

Fig. 6. Effects of baricitinib and tofacitinib on eosinophil phagocytosis and degranulation. Purified eosinophils were pretreated with vehicle, baricitinib (500 nM and 2.5 µM) (A, n = 4) or tofacitinib (500 nM and 2.5 µM) (B, n = 4) for 30 min at 37 ◦C, incubated with opsonized Escherichia coli-FITC and analyzed by flow cytometry. Phagocytosis is presented as the percentage of E. coli-FITC-positive eosinophils. Data are shown as mean ± SEM. * P < 0.05, ** P < 0.01; One-way ANOVA. (C) Purified eosinophils were pretreated with vehicle, baricitinib or tofacitinib (500 nM) for 30 min at 37 ◦C and then stimulated with complement 5a for 30 min at 37 ◦C. The release of EPO activity into the supernatant was determined by photometry. Data were expressed as a percentage of the vehicle response (unstimulated) and are shown as the mean ± SEM; n = 14. Two-way ANOVA.

Journal: Biochemical pharmacology

Article Title: The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

doi: 10.1016/j.bcp.2021.114690

Figure Lengend Snippet: Fig. 6. Effects of baricitinib and tofacitinib on eosinophil phagocytosis and degranulation. Purified eosinophils were pretreated with vehicle, baricitinib (500 nM and 2.5 µM) (A, n = 4) or tofacitinib (500 nM and 2.5 µM) (B, n = 4) for 30 min at 37 ◦C, incubated with opsonized Escherichia coli-FITC and analyzed by flow cytometry. Phagocytosis is presented as the percentage of E. coli-FITC-positive eosinophils. Data are shown as mean ± SEM. * P < 0.05, ** P < 0.01; One-way ANOVA. (C) Purified eosinophils were pretreated with vehicle, baricitinib or tofacitinib (500 nM) for 30 min at 37 ◦C and then stimulated with complement 5a for 30 min at 37 ◦C. The release of EPO activity into the supernatant was determined by photometry. Data were expressed as a percentage of the vehicle response (unstimulated) and are shown as the mean ± SEM; n = 14. Two-way ANOVA.

Article Snippet: In some experiments eosinophils from healthy donors were pretreated with vehicle, baricitinib (200 nM; TargetMol) or tofacitinib (200 nM; TargetMol) for 30 min at 37 ◦C and stimulated with vehicle or IL-5 (100 pM) for 10 min at 37 ◦C prior to the staining.

Techniques: Purification, Incubation, Flow Cytometry, Activity Assay

Fig. 7. Effects of baricitinib and tofacitinib on eosinophil apoptosis. Purified eosinophils were cultured in vehicle or IL-5 100 pM-treated medium, supplemented with or without baricitinib (BARI, 500 nM) or tofacitinib (TOFA, 500 nM) for 18 h. Apoptosis and necrosis were detected by flow cytometry using FITC-annexin-V/ propidium iodide (PI). Annexin/PI double-negative cells were identified as live cells (A), annexin positive/PI negative cells as early apoptotic cells (B), annexin/PI double-positive cells as late apoptotic cells and annexin negative/PI positive cells as necrotic cells (D). Data are expressed as % of total cells and shown as mean ± SEM of 11 independent experiments. * P < 0.05, ** P < 0.01, *** P < 0.005; two-way ANOVA.

Journal: Biochemical pharmacology

Article Title: The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

doi: 10.1016/j.bcp.2021.114690

Figure Lengend Snippet: Fig. 7. Effects of baricitinib and tofacitinib on eosinophil apoptosis. Purified eosinophils were cultured in vehicle or IL-5 100 pM-treated medium, supplemented with or without baricitinib (BARI, 500 nM) or tofacitinib (TOFA, 500 nM) for 18 h. Apoptosis and necrosis were detected by flow cytometry using FITC-annexin-V/ propidium iodide (PI). Annexin/PI double-negative cells were identified as live cells (A), annexin positive/PI negative cells as early apoptotic cells (B), annexin/PI double-positive cells as late apoptotic cells and annexin negative/PI positive cells as necrotic cells (D). Data are expressed as % of total cells and shown as mean ± SEM of 11 independent experiments. * P < 0.05, ** P < 0.01, *** P < 0.005; two-way ANOVA.

Article Snippet: In some experiments eosinophils from healthy donors were pretreated with vehicle, baricitinib (200 nM; TargetMol) or tofacitinib (200 nM; TargetMol) for 30 min at 37 ◦C and stimulated with vehicle or IL-5 (100 pM) for 10 min at 37 ◦C prior to the staining.

Techniques: Purification, Cell Culture, Flow Cytometry

Fig. 8. Effects of baricitinib and tofacitinib on HDM-induced lung inflammation and airway hyperresponsiveness. (A) On day 1, eight-week-old female BALB/c mice were sensitized intranasally with 1 µg HDM and challenged by intranasal application of 10 µg HDM per day from day 7 to 12. From day 8 to 14 mice received intragastric applications of tofacitinib (TOFA, 50 µmol, twice a day) and baricitinib (BARI, 50 µmol, once a day). (B) Gating strategy for lung single cell suspensions. After single cell and CD45pos gating, eosinophils were identified as CD11cneg/Siglec Fpos and alveolar macrophages as CD11cpos/Siglec Fpos cells. CD11c/ Siglec F double negative cells were characterized as CD11bpos/Ly6Gpos neutrophils, CD11bpos/Ly6Gneg monocytes and FSC/SSClow CD11bneg/Ly6Gneg lymphocytes. On day 15, (C) lungs, (D) spleens, and (E) bone marrow were taken from six mice per group and inflammatory cells were analyzed by flow cytometry: Total CD45pos

Journal: Biochemical pharmacology

Article Title: The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

doi: 10.1016/j.bcp.2021.114690

Figure Lengend Snippet: Fig. 8. Effects of baricitinib and tofacitinib on HDM-induced lung inflammation and airway hyperresponsiveness. (A) On day 1, eight-week-old female BALB/c mice were sensitized intranasally with 1 µg HDM and challenged by intranasal application of 10 µg HDM per day from day 7 to 12. From day 8 to 14 mice received intragastric applications of tofacitinib (TOFA, 50 µmol, twice a day) and baricitinib (BARI, 50 µmol, once a day). (B) Gating strategy for lung single cell suspensions. After single cell and CD45pos gating, eosinophils were identified as CD11cneg/Siglec Fpos and alveolar macrophages as CD11cpos/Siglec Fpos cells. CD11c/ Siglec F double negative cells were characterized as CD11bpos/Ly6Gpos neutrophils, CD11bpos/Ly6Gneg monocytes and FSC/SSClow CD11bneg/Ly6Gneg lymphocytes. On day 15, (C) lungs, (D) spleens, and (E) bone marrow were taken from six mice per group and inflammatory cells were analyzed by flow cytometry: Total CD45pos

Article Snippet: In some experiments eosinophils from healthy donors were pretreated with vehicle, baricitinib (200 nM; TargetMol) or tofacitinib (200 nM; TargetMol) for 30 min at 37 ◦C and stimulated with vehicle or IL-5 (100 pM) for 10 min at 37 ◦C prior to the staining.

Techniques: Single Cell, Flow Cytometry

Difference between massively parallel shotgun sequencing (MPSS) and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal testing (gNIPT) aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Difference between massively parallel shotgun sequencing (MPSS) and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal testing (gNIPT) aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Reported accuracy of commercially available genomics‐based non‐invasive prenatal tests a

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Reported accuracy of commercially available genomics‐based non‐invasive prenatal tests a

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Current clinical pathway and three proposed uses of genomics‐based non‐invasive prenatal testing (gNIPT). Currently (on the left), pregnant women can have a prenatal screening test consisting of biomarkers or ultrasound, or both. For high‐risk pregnant women, an invasive diagnostic test (karyotyping) is offered. In the present review, we propose 3 different clinical pathways. First, gNIPT could be used as a triage test, to decide which pregnant women should receive further testing. Second, gNIPT could be used to replace current prenatal screening tests. Finally, gNIPT could be used to replace current invasive diagnostic tests (if diagnostic performance permits). At any point in a clinical pathway, a pregnant woman may decide not to proceed with other tests (not shown in the figure). Figure was designed by CL, JB, MB and YT.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Current clinical pathway and three proposed uses of genomics‐based non‐invasive prenatal testing (gNIPT). Currently (on the left), pregnant women can have a prenatal screening test consisting of biomarkers or ultrasound, or both. For high‐risk pregnant women, an invasive diagnostic test (karyotyping) is offered. In the present review, we propose 3 different clinical pathways. First, gNIPT could be used as a triage test, to decide which pregnant women should receive further testing. Second, gNIPT could be used to replace current prenatal screening tests. Finally, gNIPT could be used to replace current invasive diagnostic tests (if diagnostic performance permits). At any point in a clinical pathway, a pregnant woman may decide not to proceed with other tests (not shown in the figure). Figure was designed by CL, JB, MB and YT.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Diagnostic Assay

Characteristics of included studies by type of  gNIPT

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Characteristics of included studies by type of gNIPT

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Multiplexing, Clinical Proteomics, Sequencing, Multiplex Assay, Next-Generation Sequencing, Biomarker Discovery, Software

Performance of  gNIPT  for detection of T13

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of T13

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Manufacturers of  gNIPT  used in the included studies by prior risk of fetal aneuploidy

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Manufacturers of gNIPT used in the included studies by prior risk of fetal aneuploidy

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Reasons for patient exclusion

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Reasons for patient exclusion

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Amplification, Sequencing, Control, Sampling, Clinical Proteomics, Biomarker Discovery

Proportion of pregnant women with a reference standard and assay failure during  gNIPT  process

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Proportion of pregnant women with a reference standard and assay failure during gNIPT process

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Sampling

Performance of  gNIPT  for detection of 45,X

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of 45,X

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Performance of  gNIPT  for detection of autosomes aneuploidies (T21, T18 and T13 combined)

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of autosomes aneuploidies (T21, T18 and T13 combined)

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Performance of  gNIPT  for detection of sex chromosome aneuploidies (45,X, 47,XXX, 47,XXY and 47,XYY combined) a

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of sex chromosome aneuploidies (45,X, 47,XXX, 47,XXY and 47,XYY combined) a

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for targeted massively parallel sequencing (TMPS).

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for targeted massively parallel sequencing (TMPS).

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Sequencing

Risk of bias and applicability concerns (all tests included): review authors' judgements about each domains presented as percentages across included studies. MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Risk of bias and applicability concerns (all tests included): review authors' judgements about each domains presented as percentages across included studies. MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Summary characteristics of included studies

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Summary characteristics of included studies

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Diagnostic Assay, Shotgun Sequencing, Sequencing, Sampling, Selection

Performance of  gNIPT  for detection of T21

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of T21

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Performance of  gNIPT  for detection of T18

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of T18

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Forest plot of MPSS and TMPS for T21 in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T21 in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for T21 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T21 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for T18 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T18 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for T13 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T13 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for 45,X in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for 45,X in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for 47,XXX, 47,XXY and 47,XYY in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for 47,XXX, 47,XXY and 47,XYY in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Data for 47,XXX, 47,XXY and 47,XYY according to the prior risk of fetal aneuploidy and  gNIPT  approach

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Data for 47,XXX, 47,XXY and 47,XYY according to the prior risk of fetal aneuploidy and gNIPT approach

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13 combined) in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13 combined) in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Subgroup analyses of MPSS and  TMPS  (type of pregnancy and gestational age)

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Subgroup analyses of MPSS and TMPS (type of pregnancy and gestational age)

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13) in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13) in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for SCA (45,X, 47,XXX, 47,XXY and 47,XYY combined) in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for SCA (45,X, 47,XXX, 47,XXY and 47,XYY combined) in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of traditional screening tests for T21, T18 and T13 in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of traditional screening tests for T21, T18 and T13 in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of comparative studies of TMPS and traditional screening tests for autosomes (T21, T18 and T13 combined) in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of comparative studies of TMPS and traditional screening tests for autosomes (T21, T18 and T13 combined) in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Direct comparisons of  gNIPT  and traditional screening tests for autosomes (T21, T18 and T13 combined) in unselected population of pregnant women undergoing aneuploidy screening

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Direct comparisons of gNIPT and traditional screening tests for autosomes (T21, T18 and T13 combined) in unselected population of pregnant women undergoing aneuploidy screening

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Forest plot of traditional screening tests for autosomes (T21, T18 and T13 combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of traditional screening tests for autosomes (T21, T18 and T13 combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13 combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13 combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for T21, T18 or T13 in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T21, T18 or T13 in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for SCA (45,X, 47,XXX, 47,XXY and 47,XYY combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for SCA (45,X, 47,XXX, 47,XXY and 47,XYY combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for 45,X, 47,XXY or 47,XYY in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for 45,X, 47,XXY or 47,XYY in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques: Shotgun Sequencing, Sequencing

Sensitivity analyses

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Sensitivity analyses

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS T21.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS T21.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS T18.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS T18.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS T13.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS T13.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS 45,X.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS 45,X.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS 47,XXX.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS 47,XXX.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS 47,XXY.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS 47,XXY.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS 47,XYY.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS 47,XYY.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS all 7 aneuploidies.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS all 7 aneuploidies.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS, autosomes.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS, autosomes.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

TMPS, SCA.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: TMPS, SCA.

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Data tables by test

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Data tables by test

Article Snippet: Index and comparator tests , gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health..

Techniques:

Difference between massively parallel shotgun sequencing (MPSS) and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal testing (gNIPT) aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Difference between massively parallel shotgun sequencing (MPSS) and targeted massively parallel sequencing (TMPS). Genomics‐based non‐invasive prenatal testing (gNIPT) aims to count the number of copies of DNA fragments from the chromosomes of interest (chromosome 21 (Chrom. 21) in this example) present in circulating cell‐free DNA (ccfDNA) from a pregnant woman, relative to a reference set of chromosomes (Ref. Chrom.). DNA fragments circulating in maternal blood in the case of a euploid (left) and aneuploid (right) pregnancy are illustrated (top). MPSS produces a large number of sequence reads from all chromosomes while TMPS generates a larger proportion of reads from the chromosomes of interest (bottom). In both methods, sequence reads can be used to detect a slight excess of fetal genomic material coming from the chromosome of interest. Figure was created by FR.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Characteristics of included studies by type of gNIPT

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Characteristics of included studies by type of gNIPT

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Multiplexing, Clinical Proteomics, Sequencing, Multiplex Assay, Next-Generation Sequencing, Biomarker Discovery, Software

Performance of  gNIPT  for detection of T13

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of T13

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Proportion of pregnant women with a reference standard and assay failure during  gNIPT  process

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Proportion of pregnant women with a reference standard and assay failure during gNIPT process

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Sampling

Performance of  gNIPT  for detection of 45,X

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of 45,X

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Performance of  gNIPT  for detection of autosomes aneuploidies (T21, T18 and T13 combined)

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of autosomes aneuploidies (T21, T18 and T13 combined)

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Performance of  gNIPT  for detection of sex chromosome aneuploidies (45,X, 47,XXX, 47,XXY and 47,XYY combined) a

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of sex chromosome aneuploidies (45,X, 47,XXX, 47,XXY and 47,XYY combined) a

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Risk of bias and applicability concerns (all tests included): review authors' judgements about each domains presented as percentages across included studies. MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Risk of bias and applicability concerns (all tests included): review authors' judgements about each domains presented as percentages across included studies. MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Summary characteristics of included studies

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Summary characteristics of included studies

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Diagnostic Assay, Shotgun Sequencing, Sequencing, Sampling, Selection

Performance of  gNIPT  for detection of T21

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of T21

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Performance of  gNIPT  for detection of T18

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Performance of gNIPT for detection of T18

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Forest plot of MPSS and TMPS for T21 in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T21 in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for T21 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T21 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for T18 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T18 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for T13 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T13 in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for 45,X in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for 45,X in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for 47,XXX, 47,XXY and 47,XYY in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for 47,XXX, 47,XXY and 47,XYY in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Data for 47,XXX, 47,XXY and 47,XYY according to the prior risk of fetal aneuploidy and  gNIPT  approach

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Data for 47,XXX, 47,XXY and 47,XYY according to the prior risk of fetal aneuploidy and gNIPT approach

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13 combined) in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13 combined) in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Subgroup analyses of  MPSS  and  TMPS  (type of pregnancy and gestational age)

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Subgroup analyses of MPSS and TMPS (type of pregnancy and gestational age)

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13) in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13) in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for SCA (45,X, 47,XXX, 47,XXY and 47,XYY combined) in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for SCA (45,X, 47,XXX, 47,XXY and 47,XYY combined) in pregnant women selected at high risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of traditional screening tests for T21, T18 and T13 in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of traditional screening tests for T21, T18 and T13 in unselected pregnant women undergoing aneuploidy screening. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Direct comparisons of  gNIPT  and traditional screening tests for autosomes (T21, T18 and T13 combined) in unselected population of pregnant women undergoing aneuploidy screening

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Direct comparisons of gNIPT and traditional screening tests for autosomes (T21, T18 and T13 combined) in unselected population of pregnant women undergoing aneuploidy screening

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Forest plot of traditional screening tests for autosomes (T21, T18 and T13 combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of traditional screening tests for autosomes (T21, T18 and T13 combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13 combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for autosomes (T21, T18 and T13 combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for T21, T18 or T13 in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for T21, T18 or T13 in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for SCA (45,X, 47,XXX, 47,XXY and 47,XYY combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for SCA (45,X, 47,XXX, 47,XXY and 47,XYY combined) in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Forest plot of MPSS and TMPS for 45,X, 47,XXY or 47,XYY in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Forest plot of MPSS and TMPS for 45,X, 47,XXY or 47,XYY in pregnant women with mixed prior risk of fetal aneuploidy. FN: false negative, FP: false positive, MPSS: massively parallel shotgun sequencing, TMPS: targeted massively parallel sequencing, TN: true negative and TP: true positive.

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: Shotgun Sequencing, Sequencing

Sensitivity analyses

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Sensitivity analyses

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques:

Data tables by test

Journal: The Cochrane Database of Systematic Reviews

Article Title: Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

doi: 10.1002/14651858.CD011767.pub2

Figure Lengend Snippet: Data tables by test

Article Snippet: Index and comparator tests , gNIPT by TMPS or MPSS by commercial company providing gNIPT in Turkey (Ariosa Diagnostics, Inc., BGI‐Shenzhen, Illumina, Inc, Natera, Inc. and Sequenom, Inc). Blood samples for gNIPT were collected before reference standard..

Techniques: